Normal view MARC view ISBD view

Influence of magnetic anisotropy on laser-induced precession of magnetization in ferromagnetic semiconductor (Ga, Mn)As. [electronic resource]

By:

Nad'a, Tesarová

Contributor(s):

Producer: 20121024Description: 7477-81 p. digitalISSN:

1533-4880

Online resources:

Available from publisher's website

In: Journal of nanoscience and nanotechnology vol. 12

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.

Back to results

481 [Use of monoclonal antibodies in pathological diagnostics].
by Förster, S
482 Comparison of PD-L1 Expression Status between Pure-Solid Versus Part-Solid Lung Adenocarcinomas.
by Suda, Kenichi
483 Prognostic value and clinicopathological characteristics of PD-L1 overexpression in non-Hodgkin lymphoma: a meta-analysis.
by Zeng, Qiang
484 Deliver anti-PD-L1 into brain by p-hydroxybenzoic acid to enhance immunotherapeutic effect for glioblastoma.
by Guo, Haiyan
485 Mechanisms regulating PD-L1 expression on tumor and immune cells.
by Chen, Shuming
486 [B7-H1 and liver immunity].
by Geng, Lei
487 Blocking the PD-1/PD-L1 pathway in glioma: a potential new treatment strategy.
by Xue, Song
488 Programmed death-ligand 1 immunohistochemistry testing for non-small cell lung cancer in practice.
by Mino-Kenudson, Mari
489 PD-L1/PD-1 check-point in gastric carcinoma with lymphoid stroma case report with immunochemical study.
by Crescenzi, Anna
490 [Quiz: Ready, study, score!]
by Roussel, Hélène
491 Clinical Neuropathology mini-review 6-2015: PD-L1: emerging biomarker in glioblastoma?
by Preusser, Matthias
492 Delineating the Role of PD-1/PD-L1 Blockade in Advanced SCLC.
by Zimmermann, Stefan
493 The Role of Biomarkers for the Prediction of Response to Checkpoint Immunotherapy and the Rationale for the Use of Checkpoint Immunotherapy in Cervical Cancer.
by Otter, S J
494 Targeting Protein Kinases to Enhance the Response to anti-PD-1/PD-L1 Immunotherapy.
by García-Aranda, Marilina
495 Maternal soluble PD-1 levels are significantly increased in women with preeclampsia.
by Gu, Yang
496 Response to Costantini et al. "Comments on Increased Response Rates to Salvage Chemotherapy Administered after PD-1/PD-L1 Inhibitors in Patients with Non-Small Cell Lung Cancer".
by Sun, Jong-Mu
497 [A Rare Case of Pulmonary Epithelial-myoepithelial Carcinoma: Case Report and Literature Review].
by Chen, Liang
498 The Biogenesis, Biology, and Clinical Significance of Exosomal PD-L1 in Cancer.
by Tang, Yanyan
499 The PD-1/PD-L1 pathway: biological background and clinical relevance of an emerging treatment target in immunotherapy.
by Muenst, Simone
500 Next steps for cancer immune therapy.